Longevity Therapeutics
Cross-source consensus on Longevity Therapeutics from 1 sources and 5 claims.
1 sources · 5 claims
Uses
How it works
Comparisons
Evidence quality
Highlighted claims
- The practical drug-development path targets recognized diseases before seeking broader aging-related uses. — Longevity Therapeutics and Aging Biology
- Direct human lifespan trials are described as impractical for proving large lifespan extension. — Longevity Therapeutics and Aging Biology
- Statin development is presented as a precedent for using biomarkers to compress clinical trials. — Longevity Therapeutics and Aging Biology
- A mechanism that works across multiple age-related diseases could support broader use through existing regulatory mechanisms. — Longevity Therapeutics and Aging Biology
- Aging clocks may eventually become accepted biomarkers for predicting multimorbidity risk. — Longevity Therapeutics and Aging Biology